Involvement of nuclear NHERF1 in colorectal cancer progression

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 889-894

  Mangia, Anita ^a   Saponaro, Concetta ^a   Malfettone, Andrea ^a   Bisceglie, Domenico ^a   Bellizzi, Antonia ^a   Asselti, Mariaconsilia ^a   Popescu, Ondina ^a   Reshkin, Stephan J ^b   Paradiso, Angelo ^a   Simone, Giovanni ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Carcinogenesis; Immuno histochemistry; Metastatic colorectal cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR 1; SODIUM PROTON EXCHANGE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORPHOLOGY; CELLULAR DISTRIBUTION; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SODIUM-HYDROGEN ANTIPORTER;

EID: 84865340159     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1895     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin 58: 71-96, 2008.
2. Horner MJ, Ries LAG, Krapcho M, et al: SEER cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute; http://seercancergov/csr/ 1975-2006/; 2009.
3. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1: 759-767, 1990.
4. Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science 13: 268-274, 2006.
5. Bretscher A, Chambers D, Nguyen R and Reczek D: ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16: 113-143, 2000.
6. Voltz JW, Weinman EJ and Shenolikar S: Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 20: 6309-6314, 2001.
7. Mahon MJ, Donowitz M, Yun CC and Segre GV: Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 20: 858-861, 2002.
8. Shenolikar S, Voltz JW, Cunningham R and Weinman EJ: Regulation of ion transport by the NHERF family of PDZ proteins. Physiology 19: 362-369, 2004.
9. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY and Shenolikar S: The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu Rev Physiol 68: 491-505, 2006.
10. Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, Zito FA, Reshkin SJ, Simone G and Paradiso A: Biological role of NHERF1 protein expression in breast cancer. Histopathology 55: 600-608, 2009.
11. Curto M, Cole BK, Lallemand D, Liu CH and McClatchey AI: Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 5: 893-903, 2007.
12. Fanning AS and Anderson JM: PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 103: 767-772, 1999.
13. Reczek D, Berryman M and Bretscher A: Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 6: 169-179, 1997.
14. Louvet-Vallée S: ERM proteins: from cellular architecture to cell signalling. Biol Cell 92: 305-316, 2000.
15. Mahon MJ and Segre GV: Stimulation by parathyroid hormone of a NHERF-1-assembled complex consisting of the parathyroid hormone I receptor, phospholipase Cbeta, and actin increases intracellular calcium in opossum kidney cells. J Biol Chem 28: 23550-23558, 2004.
16. Fouassier L, Duan CY, Feranchak AP, et al: Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 33: 166-176, 2001.
17. Donowitz M, Cha B, Zachos NC, Brett CL, Sharma A, Tse CM and Li X: NHERF family and NHE3 regulation. J Physiol 567: 3-11, 2005.
18. + exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 8: R63, 2006.
19. Shibata T, Chuma M, Kokubu A, SakamotoM and Hirohashi S: EBP50, a beta-catenin associating protein, enhances Wnt signaling and is overexpressed in hepatocellular carcinoma. Hepatology 38: 178-186, 2003.
20. Fraenzer JT, Pan H, Minimo L Jr, Smith GM, Knauer D and Hung G: Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol 24: 1493-1500, 2003.
21. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, et al: NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 158: 57-62, 2001.
22. Song J, Bai J, Yang W, Gabrielson EW, Chan DW and Zhang Z: Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin- binding phosphoprotein 50 in breast cancer. Histopathology 51: 40-53, 2007.
23. Georgescu MM, Morales FC, Molina JR and Hayashi Y: Roles of NHERF1/EBP50 in cancer. Curr Mol Med 8: 459-468, 2008.
24. Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, Paradiso A, Casavola V, Zaccolo M and Reshkin SJ: Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell 16: 3117-3127, 2005.
25. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A and Reshkin SJ: The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18: 1768-1480, 2007.
26. Hayashi Y, Molina JR, Hamilton SR and Georgescu MM: NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 12: 1013-1022, 2010.
27. Hamilton, SR, Vogelstein, B, Kudo S, Riboli E, Nakamura S and Hainaut P: Carcinoma of the colon and rectum. In: WHO Classification of Tumors: Pathology and Genetics of Tumors of Digestive System. Hamilton SR and Aaltonen LA (eds). IARC Press, Lyon, France, pp105-119, 2000.
28. Goldstein NS, Armin M: Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92: 1331-1346, 2001.
29. Takahashi Y, Morales FC, Kreimann EL and Georgescu MM: PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signalling. EMBO J 5: 910-920, 2006.
30. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD and Georgescu MM: Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26: 5290-5299, 2007.
31. + exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 15: 5470-5480, 2004.
32. Wei Q, Shui Y, Zheng S, Wester K, Nordgren H, Nygren P, Glimelius B and Carlsson J: EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: implications for targeted radionuclide therapy. Oncol Rep 25: 3-11, 2011.
33. Ljuslinder I, Malmer B, Isaksson-Mettävainio M, Oberg A, Henriksson R, Stenling R and Palmqvist R: ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res 29: 1489-1494, 2009.
34. Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Pierantoni C and Cascinu S: Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options. Br J Cancer 97: 92-97, 2007.
35. Krasinskas AM: EGFR signaling in colorectal carcinoma. Patholog Res Int: 932932, 2011.